×
Home Current Archive Editorial board
News Contact
Review paper

Effects of perioperative statin treatment on postoperative atrial fibrillation and cardiac mortality in patients undergoing coronary artery bypass grafting: a propensity score analysis

By
Ayşegül Kunt ,
Ayşegül Kunt

Department of Cardiovascular Surgery, School of Medicine, 100.Yil University , Van , Turkey

Sedat Özcan ,
Sedat Özcan
Contact Sedat Özcan

Department of Cardiovascular Surgery, School of Medicine, 18 Mart University , Çanakkale , Turkey

Aslihan Küçüker ,
Aslihan Küçüker

Department of Cardiac Surgery, Ataturk Education and Research Hospital , Ankara , Turkey

Dolunay Odabaşi ,
Dolunay Odabaşi

Department of Cardiovascular Surgery, School of Medicine, 100.Yil University , Van , Turkey

Alper Sami Kunt
Alper Sami Kunt

Department of Cardiovascular Surgery, School of Medicine, 100.Yil University , Van , Turkey

Abstract

Aim
To evaluate the effect of perioperative statin treatment on postoperative atrial fibrillation and cardiac mortality in patients undergoing coronary artery bypass grafting.
Methods
A total of 1890 patients who underwent isolated coronary artery bypass were analyzed retrospectively, of which 425
patients (22.4%) older than 70 were included in the study. The demographic properties, preoperative, operative and postoperative data and other medications of these patients were recorded. Continuous preoperative and postoperative atorvastatin therapy were received by 124 (29.17%) patients; 301 (70.82%) patients were matched to a control group (no-statin group). The two groups were matched by propensity score analysis in terms of atrial fibrillation
development and cardiac mortality.
Results
Medical history, medical treatment, cardiovascular history, and operative characteristics demonstrated significant heterogeneity in both groups. Postoperative atrial fibrillation was similar in both groups. Before propensity score matching, the percentages of patients in postoperative atrial fibrillation with respect to Atorvastain-group and No-statin-group were 13.71 and 10.3 respectively; however, those were 13.71 and 14.51 after matching. In a multivariate regression analysis, five-vessel bypass (odds ratio OR, 2.354; 95% confidence interval CI, 0.99 to 5.57) was an independent predictor of postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting. In-hospital mortality
was higher in the Atorvastatin-group compared with the No-statingroup: 124 (8.9%) versus 301 (3.7%), respectively; p=0.027).
Conclusion
Perioperative atorvastatin treatment is not found to be associated with reduced postoperative atrial fibrillation and cardiac mortality in patients undergoing isolated coronary artery bypass grafting above the age of seventy years

References

1.
Marín F, Pascual D, Roldán V, Arribas J, Ahumada M, Tornel P. Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting. Am J Cardiol. 2006;55–60.
2.
Villareal R, Hariharan R, Liu B, Kar B, Lee V, Elayda M. Postoperative atrial fibrillation and mortality after coronary artery bypass surgery. J Am Coll Cardiol. 2004;742–8.
3.
Kalavrouziotis D, Buth K, Ali I. The impact of new-onset atrial fibrillation on in-hospital mortality following cardiac surgery. Chest. 2007;833–9.
4.
Mariscalco G, Gunnar K, Engström. Postoperative atrial fibrillation is associated with late mortality after coronary surgery, but not after valvular surgery. Ann Thorac Surg. 2009;1871–6.
5.
Ahlsson A, Bodin L, Fengsrud E, Englund A. Patients with postoperative atrial fibrillation have a doubled cardiovascular mortality. Scand Cardiovasc J. 2009;1–7.
6.
Maisel W, Rawn J, Stevenson W. Atrial fibrillation after cardiac surgery. Ann Intern Med. 2001;1061–73.
7.
Levy D, Kannel W. Postoperative atrial fibrillation and mortality: do the risks merit changes in clinical practice? J Am Coll Cardiol. 2004;749–51.
8.
Mathew J, Parks R, Savino J, Friedman A, Koch C, Mangano D. Atrial fibrillation following coronary artery bypass graft surgery. JAMA. 1996;300–6.
9.
Creswell L, Schuessler R, Rosenbloom M, Cox J. Hazards of postoperative atrial arrhythmias. Ann Thorac Surg. 1993;539–49.
10.
Mithani S, Akbar M, Johnson D, Kuskowski M, Apple K, Bonawitz-Conlin J. Dose dependent effect of statins on postoperative atrial fibrillation after cardiac surgery among patients treated with beta blockers. J Cardiothorac Surg. 2009;61.
11.
Kourliouros A, Souza D, Roberts A, Marciniak N, Tsiouris A, Valencia A, et al. Dose-related effect of statins on atrial fibrillation after cardiac surgery. Ann Thorac Surg. 2008;1515–20.
12.
Lertsburapa K, White C, Kluger J, Faheem O, Hammond J, Coleman C. Preoperative statins for the prevention of atrial fibrillation after cardiothoracic surgery. J Thorac Cardiovasc Surg. 2008;405–11.
13.
Ozaydin M, Dogan A, Varol E, Kapan S, Tuzun N, Peker O. Statin use before by-pass surgery decreases the incidence and shortens the duration of postoperative atrial fibrillation. Cardiology. 2006;117–21.
14.
Mathew J, Fontes M, Ramsay T, Duke J, Mazer P, C. Investigators of the Ischemia Research and Education Foundation; Multicenter Study of Perioperative Ischemia Research Group. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA. 2004;1720–9.
15.
Dotani M, Elnicki D, Jain A, Gibson C. Effect of preoperative statin therapy and cardiac outcomes after coronary artery bypass grafting. Am J Cardiol. 2000;1128–30.
16.
Crystal E, Connolly S, Sleik K, Ginger T. Yusuf S. Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery: a meta-analysis. Circulation. 2002;75–80.
17.
Burgess D, Kilborn M, Keech A. Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a metaanalysis. Eur Heart J. 2006;2846–57.
18.
Almassi G, Schowalter T, Nicolosi A, Aggarwal A, Moritz T, Henderson W. Atrial fibrillation after cardiac surgery: a major morbid event? Ann Surg. 1997;501–13.
19.
Mariscalco G, Klersy C, Zanobini M, Banach M, Ferrarese S, Borsani P. Atrial fibrillation after isolated coronary surgery affects late survival. Circulation. 2008;1612–8.
20.
Patti G, Chello M, Candura D, Pasceri V, ’ambrosio D, Covino A, et al. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMY-DA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study. Circulation. 2006;1455–61.
21.
Chen W, Krishnan G, Sood N, Kluger J, Coleman C. Effect of statins on atrial fibrillation after cardiac surgery: A duration-and dose-response meta-analysis. J Thorac Cardiovasc Surg. 2010;364–72.
22.
Butler J, Harriss D, Sinclair M, Westaby S. Amiodarone prophylaxis for tachcardias after coronary artery surgery: a randomized, doubleblind, placebo controlled trial. Br Heart J. 1993;56–60.
23.
Hashimoto K, Ilstrup D, Schaff H. Influence of clinical and hemodynamic variables on risk of supraventricular tachycardia after coronary artery bypass. J Thorac Cardiovasc Surg. 1991;56–65.
24.
Aranki S, Shaw D, Adams D, Rizzo R, Couper G, Vandervliet M. Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. Circulation. 1996;390–7.
25.
Mariscalco G, Klersy C, Zanobini M, Banach M, Ferrarese S, Borsani P. Atrial fibrillation following coronary artery bypass graft surgery: predictors, outcomes, and resource utilization. JAMA. 1996;300–6.

Citation

Authors retain copyright. This work is licensed under a Creative Commons Attribution 4.0 International License. Creative Commons License

 

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.